Australia's Optiscan Imaging gains on Mayo clinic collaboration progress
13/05/2025 03:53
** Optiscan Imaging OIL.AX rises 6.82% to A$0.1175; marks biggest percentage gain since April 17 ** Imaging technologies maker and Mayo Clinic have come together to advance the development of a digital endomicroscopic imaging system for use in robotic surgery ** Co says development plan on track and project's next phase will take place at the Mayo Clinic's Florida campus ** OIL loses 29% this year, as of last close (Reporting by Sherin Sunny in Bengaluru) ((Sherin.Sunny@thomsonreuters.com;))
Recent news on Optiscan Imaging
See all newsAustralia's Optiscan rises after FDA filing for surgery imaging device
Brief: Optiscan Imaging Lodges US FDA 510(K) Submission For Inform Digital Pathology Device
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australia's Optiscan Imaging gains on signing new cross-border research deal
Brief: Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market